PHOENIX, Oct. 2 -- Vital Living, Inc. (OTC Bulletin Board: VTLV.OB), today announced the appointment of Marcus Feder, CPA as our new Chief Financial Officer. Mr. Feder joins Vital Living after a 16-year career as a financial professional, most recently serving as Chief Financial Officer for Single Crystal Technologies, LLC, a Phoenix-based technology company. Mr. Feder will be working at the Vital Living headquarters in Phoenix and his appointment is a strategic addition to the Company's strong management team. He reports to Brad Edson, Chairman and CEO, and Stuart Benson, President of Vital Living.
"I am pleased to welcome Marcus to Vital Living's management team," said Brad Edson, Chairman and CEO of Vital Living. "Marcus'extensive experience in working with technology and healthcare companies will help to accelerate and finance Vital Living's growth as we look to expand through internal growth and acquisitions."
Mr. Feder, 47, served as Chief Financial Officer for Single Crystal Technologies, LLC (SCT), a privately-held semiconductor technology company, beginning in 2001. His responsibilities included financial planning and managing the company's accounting operations. He also established relationships with investment banks, high-tech law firms and venture capital funds. For the prior 12 years, Feder worked at Ernst & Young, a global leader in professional services, rising to serve as Senior Manager from 1998 to 2001 in its Audit, Business Advisory Services division.
"I am pleased to join a strong management team at Vital Living," said Feder. "This is a unique opportunity for me to become a part of a Company on the cutting edge of nutraceutical product development. Utilizing proprietary drug delivery systems to form quick-release products positions Vital Living at the forefront of this industry, and I look forward to contributing to the Company's successes."
About Vital Living
Vital Living develops and markets evidence-based nutraceuticals, designed to be incorporated by physicians into a standard physician/patient program, and supported by a specially designed compliance regimen. The Company's initial area of focus was cardiovascular health, the leading health concern in America affecting 60 million consumers. Essentum(TM), currently undergoing clinical trials, is already being endorsed by the Arizona Heart Institute and prescribed throughout the United States. Vital Living also owns MAF Bionutritionals and the Christophers Herb line of over 300 products. For more information, visit www.vitalliving.com.
Except for any historical information, the matters discussed in this press release contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve risks and uncertainties, including activities, events or developments that the company expects, believes or anticipates will or may occur in the future. A number of factors could cause actual results to differ from those indicated in the forward- looking statements, including the company's ability to continue to successfully market and provide its products and services and maintain their effectiveness, the continuation of the arrangements with the company's product development partners, the ability of the company to meet its financial projections, and general economic conditions. Such statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and that actual results or developments may differ materially from those set forth in the forward-looking statements. The company undertakes no obligation to publicly update or revise forward-looking statements, whether as a result of new information or otherwise.